Clinical Sciences
Does the Evaluation of Coagulation Factors Contribute to Etiological Diagnosis of Pleural Effusions?
Marcelo Alexandre Costa VazI, Francisco Suso VargasI, Felipe Costa de Andrade MarinhoI, Élbio Antonio D’AmicoII, Tânia Rubia Flores RochaII, Lisete Ribeiro TeixeiraI
I Pleural Laboratory, Pulmonary Division, Heart Institute (InCor), Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo - São Paulo/SP, Brazil
II Hemostasis Laboratory, Hematology Service, Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo - São Paulo/SP, Brazil., Tel: 55 11 3069.5034
Read
968
Timeswas read the article
286
Total PDF
682
Total HTML
Share statistics
array:24 [ "pii" => "S1807593222025595" "issn" => "18075932" "doi" => "10.1590/S1807-59322009000900010" "estado" => "S300" "fechaPublicacion" => "2009-09-01" "aid" => "20222559" "copyright" => "CLINICS" "copyrightAnyo" => "2009" "documento" => "article" "crossmark" => 0 "licencia" => "https://creativecommons.org/licenses/by-nc/3.0/" "subdocumento" => "fla" "cita" => "Clinics. 2009;64:891-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:19 [ "pii" => "S1807593222025601" "issn" => "18075932" "doi" => "10.1590/S1807-59322009000900011" "estado" => "S300" "fechaPublicacion" => "2009-09-01" "aid" => "20222560" "copyright" => "CLINICS" "documento" => "article" "crossmark" => 0 "licencia" => "https://creativecommons.org/licenses/by-nc/3.0/" "subdocumento" => "fla" "cita" => "Clinics. 2009;64:897-901" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Basic Research</span>" "titulo" => "Variability in the Origin of the Obturator Artery" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "897" "paginaFinal" => "901" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "f1-cln64_9p897" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 965 "Ancho" => 794 "Tamanyo" => 139200 ] ] "descripcion" => array:1 [ "en" => "<p id="spara10" class="elsevierStyleSimplePara elsevierViewall">Right side of a pelvis showing the origin of the obturator artery (OA) from the posterior division (PD) of the internal iliac artery (IIA). AD- anterior division, EIA- External iliac artery, ON- obturator nerve, OV- obturator vein</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Mangala M. Pai, Ashwin Krishnamurthy, Latha V Prabhu, Manohar V. Pai, Senthil A. Kumar, Gavishiddappa A. Hadimani" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Mangala M." "apellidos" => "Pai" ] 1 => array:2 [ "nombre" => "Ashwin" "apellidos" => "Krishnamurthy" ] 2 => array:2 [ "nombre" => "Latha V" "apellidos" => "Prabhu" ] 3 => array:2 [ "nombre" => "Manohar V." "apellidos" => "Pai" ] 4 => array:2 [ "nombre" => "Senthil A." "apellidos" => "Kumar" ] 5 => array:2 [ "nombre" => "Gavishiddappa A." "apellidos" => "Hadimani" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1807593222025601?idApp=UINPBA00004N" "url" => "/18075932/0000006400000009/v1_202212060758/S1807593222025601/v1_202212060758/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S1807593222025583" "issn" => "18075932" "doi" => "10.1590/S1807-59322009000900009" "estado" => "S300" "fechaPublicacion" => "2009-09-01" "aid" => "20222558" "copyright" => "CLINICS" "documento" => "article" "crossmark" => 0 "licencia" => "https://creativecommons.org/licenses/by-nc/3.0/" "subdocumento" => "fla" "cita" => "Clinics. 2009;64:885-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Clinical Sciences</span>" "titulo" => "Comparative Evaluation of Oculometric Variables in Graves’ Ophthalmopathy" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "885" "paginaFinal" => "889" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "f2-cln64_9p885" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 504 "Ancho" => 976 "Tamanyo" => 48735 ] ] "descripcion" => array:1 [ "en" => "<p id="spara20" class="elsevierStyleSimplePara elsevierViewall">Comparison of eye measures between GO and non-GO patients adjusted to iris diameter (mean ± standard deviation)</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Hélio Amante Miot, Leonardo Parr dos Santos Fernandes, Edson Nassib Jorge, Daniel Rosito Pivotto, Célia Regina Nogueira, Gláucia Maria Ferreira da Silva Mazeto" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Hélio Amante" "apellidos" => "Miot" ] 1 => array:2 [ "nombre" => "Leonardo Parr dos Santos" "apellidos" => "Fernandes" ] 2 => array:2 [ "nombre" => "Edson Nassib" "apellidos" => "Jorge" ] 3 => array:2 [ "nombre" => "Daniel Rosito" "apellidos" => "Pivotto" ] 4 => array:2 [ "nombre" => "Célia Regina" "apellidos" => "Nogueira" ] 5 => array:2 [ "nombre" => "Gláucia Maria Ferreira da Silva" "apellidos" => "Mazeto" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1807593222025583?idApp=UINPBA00004N" "url" => "/18075932/0000006400000009/v1_202212060758/S1807593222025583/v1_202212060758/en/main.assets" ] "en" => array:18 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Clinical Sciences</span>" "titulo" => "Does the Evaluation of Coagulation Factors Contribute to Etiological Diagnosis of Pleural Effusions?" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "891" "paginaFinal" => "895" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Marcelo Alexandre Costa Vaz, Francisco Suso Vargas, Felipe Costa de Andrade Marinho, Élbio Antonio D’Amico, Tânia Rubia Flores Rocha, Lisete Ribeiro Teixeira" "autores" => array:6 [ 0 => array:3 [ "nombre" => "Marcelo Alexandre Costa" "apellidos" => "Vaz" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">I</span>" "identificador" => "afI-cln64_9p891" ] ] ] 1 => array:3 [ "nombre" => "Francisco Suso" "apellidos" => "Vargas" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">I</span>" "identificador" => "afI-cln64_9p891" ] ] ] 2 => array:3 [ "nombre" => "Felipe Costa" "apellidos" => "de Andrade Marinho" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">I</span>" "identificador" => "afI-cln64_9p891" ] ] ] 3 => array:3 [ "nombre" => "Élbio Antonio" "apellidos" => "D’Amico" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">II</span>" "identificador" => "afII-cln64_9p891" ] ] ] 4 => array:4 [ "nombre" => "Tânia Rubia Flores" "apellidos" => "Rocha" "email" => array:1 [ 0 => "lisetepneumo@yahoo.com.br" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">II</span>" "identificador" => "afII-cln64_9p891" ] ] ] 5 => array:3 [ "nombre" => "Lisete Ribeiro" "apellidos" => "Teixeira" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">I</span>" "identificador" => "afI-cln64_9p891" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Pleural Laboratory, Pulmonary Division, Heart Institute (InCor), Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo - São Paulo/SP, Brazil" "etiqueta" => "I" "identificador" => "afI-cln64_9p891" ] 1 => array:3 [ "entidad" => "Hemostasis Laboratory, Hematology Service, Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo - São Paulo/SP, Brazil., Tel: 55 11 3069.5034" "etiqueta" => "II" "identificador" => "afII-cln64_9p891" ] ] ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "f1-cln64_9p891" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1735 "Ancho" => 804 "Tamanyo" => 158395 ] ] "descripcion" => array:1 [ "en" => "<p id="spara10" class="elsevierStyleSimplePara elsevierViewall">Fibrinogen and fragment 1+2 levels (mean ± standard error) in transudates, exudates (E), parapneumonic (P), tuberculosis (Tb) and cancer (M). * p < 0.05 (x transudate)</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="cesec10" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle70">INTRODUCTION</span><p id="para10" class="elsevierStylePara elsevierViewall">The pleural layers covering the lungs (visceral) and the thoracic wall (parietal) define the pleural cavity, which is responsible for several important functions, including the maintenance of homeostasis. In this context, the interaction between immunologic and metabolic pleural factors should be considered. Their imbalance triggers a sequence of events that generally culminates with the development of a pleural effusion.<a class="elsevierStyleCrossRef" href="#bib1">1</a> According to the pathologic changes, the accumulated fluid is classified as a transudate (an imbalance between the hydrostatic and oncotic pressures in a normal pleura) or an exudate (an inflammatory process with pleural injury).</p><p id="para20" class="elsevierStylePara elsevierViewall">Characteristically, an exudative effusion demonstrates increased cellularity, protein levels and inflammatory markers.<a class="elsevierStyleCrossRefs" href="#bib2">2,3</a> The contribution of the coagulation system is fundamental to the maintenance of homeostasis and should be considered due to its close relationship to the inflammatory process. The coagulation system prevents hemorrhage and initiates tissue repair and remodeling, in addition to orchestrating cellular proliferation, cellular migration and synthesis of inflammatory mediators. The coagulation system, when chronically activated and in the presence of an inflammatory state, can generate adverse effects such as chronic release of procoagulant factors (e.g., tissue factor), cellular activation (adhesion molecules), protein modulation (transformation of fibrinogen into fibrin), and even histological changes promoted by cytokines.<a class="elsevierStyleCrossRef" href="#bib4">4</a> All these changes in exudative effusions contribute to tissue remodeling and lead to pleural thickening, trapped lung and functional impairment.<a class="elsevierStyleCrossRef" href="#bib4">4</a> It is worth noting that chronic transudates, which have no inflammatory response, are rarely associated with pleural thickening.<a class="elsevierStyleCrossRef" href="#bib1">1</a> To recognize the contribution of the coagulation system to the differential diagnosis of pleural effusions, we evaluated the laboratory profiles of coagulation and fibrinolysis in pleural fluids of different etiologies.</p></span><span id="cesec20" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle80">MATERIALS AND METHODS</span><p id="para30" class="elsevierStylePara elsevierViewall">The present study was approved by the Research Ethics Committee of the University and informed written consent was obtained from the patients. Fifty-four patients with a diagnosed pleural effusion were sequentially selected: 15 transudates and 39 exudates (9 parapneumonic, 15 tuberculosis and 15 cancers). Inclusion was based on the presence of a defined etiology and the absence of coagulation disturbances: normal serum values for thrombin time (TT), activated partial thromboplastin time (APTT) and prothrombin time (PT). The presence of an associated pneumothorax determined exclusion.</p><p id="para40" class="elsevierStylePara elsevierViewall">The patients underwent thoracocentesis and, in some cases, a parietal pleural biopsy. Blood and fluid samples were collected at same time to differentiate transudate from exudates based on Light’s criteria.<a class="elsevierStyleCrossRef" href="#bib2">2</a> The etiological diagnosis of the exudates was established by considering, in addition to the clinical parameters, the following criteria:</p><p id="para50" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="celist10"><li class="elsevierStyleListItem" id="celistitem10"><p id="para60" class="elsevierStylePara elsevierViewall">* <span class="elsevierStyleItalic">Parapneumonic</span>: radiological study compatible with pneumonia, neutrophilic pleural fluid with a positive culture or the presence of bacteria.</p></li><li class="elsevierStyleListItem" id="celistitem20"><p id="para70" class="elsevierStylePara elsevierViewall">* <span class="elsevierStyleItalic">Tuberculosis</span>: lymphocytic fluid (>80%) with rare mesothelial cells (<5%) and an elevated adenosine deaminase (> 40 Ul). The presence of <span class="elsevierStyleItalic">Mycobacterium tuberculosis</span> in the fluid, in the pleural fragment and/or granuloma (with or without caseation) in the histology.</p></li><li class="elsevierStyleListItem" id="celistitem30"><p id="para80" class="elsevierStylePara elsevierViewall">* <span class="elsevierStyleItalic">Malignant</span>: positive oncotic cytology in the fluid or in the pleural fragment.</p></li></ul></p><p id="para90" class="elsevierStylePara elsevierViewall">Samples of blood and pleural fluid were collected in siliconated tubes containing citrate. Thrombin time, activated partial thromboplastin time and prothrombin time were immediately evaluated. Samples of fluid were centrifuged and frozen at − 80°C for later measurement of fibrinogen, prothrombin fragment 1+2 (F1+2), thrombin-antithrombin complex (TAT), fibrin degradation products (FDP) and D-dimer levels (enzymatic reaction - ELISA with photometric reading).</p><span id="cesec30" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle90">Statistical analysis</span><p id="para100" class="elsevierStylePara elsevierViewall">Data are presented as means and standard error. To compare the groups, Kruskal-Wallis non-parametric analysis of variance followed by Dunn’s test was performed. The power of the study was calculated to 0.8 and p-values lower than 0.05 were considered significant. The statistical program used was Systat Software 2006 (Sigma Stat 3.5; California, USA).</p></span></span><span id="cesec40" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle100">RESULTS</span><p id="para110" class="elsevierStylePara elsevierViewall">All patients had normal blood coagulation profiles. Irrespective of etiology, the pleural fluid samples showed higher prothrombin times (PT) and activated partial thromboplastin (aPTT) than those observed in blood.</p><p id="para120" class="elsevierStylePara elsevierViewall">With respect to plasma, the pleural levels of fibrinogen were reduced (transudates and exudates), while in all other tests, the levels were increased. Significant differences were observed in the pleural levels of fibrinogen between transudates and exudates (p = 0.004) and also among transudates and parapneumonic effusions (p = 0.011) secondary to tuberculosis (p = 0.023) and cancer (p = 0.005). Comparison among the exudates did not show statistically significant differences (p = 0.214); <a class="elsevierStyleCrossRef" href="#f1-cln64_9p891">Figure 1</a>.</p><elsevierMultimedia ident="f1-cln64_9p891"></elsevierMultimedia><p id="para130" class="elsevierStylePara elsevierViewall">For the levels of fragment 1+2, we noted results inverse to those observed fibrinogen. The transudates presented a significant reduction with respect to the exudates (p = 0.001) and the parapneumonic effusions (p = 0.0037) secondary to tuberculosis (p < 0.001) and cancer (p = 0.002). There were no differences among the exudates (p = 0.391); <a class="elsevierStyleCrossRef" href="#f1-cln64_9p891">Figure 1</a>.</p><p id="para140" class="elsevierStylePara elsevierViewall">The thrombin-antithrombin complex showed changes similar to F1+2, with a statistically significant increase in exudates as compared to transudates (p < 0.001). Similarly, there were differences among transudates and parapneumonic effusions (p = 0.017) secondary to tuberculosis (p < 0.001) and cancer (p = 0.001). No significant differences were observed among the exudates (p = 0.094); <a class="elsevierStyleCrossRef" href="#f2-cln64_9p891">Figure 2</a>.</p><elsevierMultimedia ident="f2-cln64_9p891"></elsevierMultimedia><p id="para150" class="elsevierStylePara elsevierViewall">The values for fibrin degradation products were not different between transudates and exudates (p = 0.42), transudates and parapneumonic effusions (p = 0.068), or secondary to tuberculosis (p = 0.798) and cancer (p = 0.933). Similar findings were observed with respect to D-dimer, with no significant differences observed between transudates and exudates (p = 0.277) or parapneumonic effusions (p = 0.811), or secondary to tuberculosis (p = 0.213) and cancer (p = 0.053); <a class="elsevierStyleCrossRef" href="#f2-cln64_9p891">Figure 2</a>.</p></span><span id="cesec50" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle110">DISCUSSION</span><p id="para160" class="elsevierStylePara elsevierViewall">This study demonstrates that the coagulation system behaves differently in transudates and exudates, reflecting the pathophysiologic mechanisms involved in the development of pleural effusions. This may be an important addition to the methods for its diagnosis.<a class="elsevierStyleCrossRefs" href="#bib5">5,6</a></p><p id="para170" class="elsevierStylePara elsevierViewall">In transudates, there is no increase in protein and cellular permeability, nor is there an inflammatory response or activation of the coagulation cascade. Homeostasis is disrupted by the imbalance between pressure and oncotic forces, resulting in fluid accumulation with minimal substrate (proteins) and reduced or absent stimuli for structural changes.</p><p id="para180" class="elsevierStylePara elsevierViewall">It has been well documented that inflammatory cytokines play important roles in the coagulation and fibrinolytic systems, which, in turn, influence the inflammatory process. This inflammation-coagulation relationship is of fundamental importance to the pathophysiology of pleural effusions. The inflammatory response that follows the injury is essential in the tissue repair phase. In this context, fibrin deposition represents the substrate for anatomical reorganization and repair.<a class="elsevierStyleCrossRefs" href="#bib1">1,7</a> However, depending on several factors, e.g., the intensity and persistence of injury, simple repair (<span class="elsevierStyleItalic">restitutio ad integrum</span>) may be replaced by fibrosis with pleural thickening and synechiae.</p><p id="para190" class="elsevierStylePara elsevierViewall">Following tissue injury, vasodilatation secondary to the inflammatory process facilitates the passage of plasma and proteins into the tissue. The binding of tissue factor with factor VII (present in the plasma) forms a complex, activating and initiating the coagulation cascade culminating in the activation of factor X. When this factor acts on prothrombin, it is cleaved into two parts: thrombin and fragment 1+2; this reflects the activation of coagulation. Thrombin, acting directly on fibrinogen, produces fibrin, which is ultimately responsible for pleural thickening. The maintenance of physiological balance is dependent on coagulation inhibitors (antithrombin, C and S proteins). Antithrombin plays an important role by linking itself to thrombin, thus, forming the thrombin-antithrombin complex and blocking thrombin activity. However, once fibrin is formed, the physiological balance is weighted toward lysis (fibrinolysis). In the presence of fibrinolytic activity, an increase in FDP and D-dimer values is observed; the latter being specific to the lysis of polymerized and stabilized fibrin. Inflammatory processes may interfere in the coagulation cascade modifying the reparatory tissue response.<a class="elsevierStyleCrossRefs" href="#bib8">8,9</a> In parapneumonic or hemorrhagic effusions, for example, the exaggerated deposition of fibrin frequently produces pleural thickening and septations or loculations.<a class="elsevierStyleCrossRef" href="#bib1">1</a></p><p id="para200" class="elsevierStylePara elsevierViewall">The results obtained show that in pleural effusions, the coagulation and fibrinolysis profiles reflect the status of the pleural layers. Among inflammatory effusions (exudates), there is coagulation activation due to the production of thrombin (characterized by the increase of F1+2) and reduction in the levels of fibrinogen (resulting from its consumption). As expected, this determines the activation of the fibrinolytic (increased levels of FDP and D-dimer) and anticoagulation (increased TAT) systems as a counterbalance to the procoagulation cascade. The increased formation of fibrin is part of the pathophysiologic mechanism of exudates and is confirmed in the analysis of loculated effusions, which show higher levels of inflammatory markers and lower fibrinolytic activity.<a class="elsevierStyleCrossRef" href="#bib10">10</a></p><p id="para210" class="elsevierStylePara elsevierViewall">We speculate that fibrin tissue incorporation as well as fibrinolytic activity occurring in the pleural cavity and observed predominantly in exudates may explain the low concentrations of fibrinogen and increased levels of D-dimer, fibrin degradation products and fragment 1+2.</p><p id="para220" class="elsevierStylePara elsevierViewall">Routine coagulation tests (PT, TT and APTT) are not adequate to recognize hypercoagulable states. However, they are specific for identifying coagulation deficiency factors in patients with hemorrhagic diseases. The patients in this study showed no changes in routine coagulation tests.</p><p id="para230" class="elsevierStylePara elsevierViewall">The increased levels of fibrin degradation products in malignant and infectious effusions (when compared to transudates) described by Asted et al.<a class="elsevierStyleCrossRef" href="#bib9">9</a> were not observed in the present study. It is of interest that our results, including those obtained with transudates, show increase levels of fibrin degradation products and D-dimer values, likely reflecting homeostatic degradation of coagulation proteins.</p><p id="para240" class="elsevierStylePara elsevierViewall">Special characteristics have been described for malignant effusions. High levels of fibrin degradation products and fragment 1+2 (markedly higher than in serum levels) reveal greater activity of the coagulation system in the pleural space, suggesting participation of this system in invasive cancer.<a class="elsevierStyleCrossRefs" href="#bib4">4,11,12</a> These findings, which denote a predominance of procoagulant activity, were not demonstrated in the present study.</p></span><span id="cesec60" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle120">CONCLUSION</span><p id="para250" class="elsevierStylePara elsevierViewall">Based on the results of this study, we conclude that the coagulation system plays an important role in pleural diseases and that the understanding of pathophysiological mechanisms may open possibilities for new diagnostic and therapeutic approaches. Differences were observed between transudates and exudates, but not among subgroups of exudates. In transudates, the lower coagulation protein influx and the decreased degradation/activation reflect a lesser degree of injury and inflammatory activity. Since there is little or no injury, the coagulation system is not activated and less reparative action and remodeling occur, diminishing the probability of pleural thickening or loculations.</p><p id="para260" class="elsevierStylePara elsevierViewall">More studies are needed to determine whether different etiologies of exudative pleural diseases affect the coagulation system.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:7 [ 0 => array:2 [ "identificador" => "xpalclavsec1584911" "titulo" => "KEYWORDS:" ] 1 => array:2 [ "identificador" => "cesec10" "titulo" => "INTRODUCTION" ] 2 => array:3 [ "identificador" => "cesec20" "titulo" => "MATERIALS AND METHODS" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "cesec30" "titulo" => "Statistical analysis" ] ] ] 3 => array:2 [ "identificador" => "cesec40" "titulo" => "RESULTS" ] 4 => array:2 [ "identificador" => "cesec50" "titulo" => "DISCUSSION" ] 5 => array:2 [ "identificador" => "cesec60" "titulo" => "CONCLUSION" ] 6 => array:1 [ "titulo" => "REFERENCES" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2009-03-18" "fechaAceptado" => "2009-06-30" "PalabrasClave" => array:1 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "KEYWORDS:" "identificador" => "xpalclavsec1584911" "palabras" => array:5 [ 0 => "Pleural diseases" 1 => "Coagulation" 2 => "Fibrinolysis" 3 => "Transudate" 4 => "Exudate" ] ] ] ] "tieneResumen" => true "resumen" => array:1 [ "en" => array:2 [ "resumen" => "<span id="ceabs10" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle10">OBJECTIVE</span><p id="spara30" class="elsevierStyleSimplePara elsevierViewall">The aim of this study was to identify the participation of the coagulation system in the differential diagnosis of pleural effusions.</p></span> <span id="ceabs20" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle20">INTRODUCTION</span><p id="spara40" class="elsevierStyleSimplePara elsevierViewall">Imbalance between immunologic and metabolic factors triggers a sequence of events resulting in pleural reactions and accumulation of fluid. The coagulation system, which is fundamental for the maintenance of homeostasis, contributes to the inflammatory process responsible for pleural effusions, and participates in cellular proliferation and migration as well as in the synthesis of inflammatory mediators.</p></span> <span id="ceabs30" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle30">METHODS</span><p id="spara50" class="elsevierStyleSimplePara elsevierViewall">We evaluated the laboratory profile of coagulation and fibrinolysis in 54 pleural fluids (15 transudates and 39 exudates).</p></span> <span id="ceabs40" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle40">RESULTS</span><p id="spara60" class="elsevierStyleSimplePara elsevierViewall">The coagulation system acts according to the pathophysiologic mechanisms involved in the development of pleural effusions. In inflammatory effusions (exudates), there is activation of coagulation with increased levels of fragment 1+2 and thrombin-antithrombin complex in addition to reduction of fibrinogen levels due to fibrinolysis and fibrin tissue incorporation. As a consequence, there is activation of the fibrinolytic system with increased levels of fibrin degradation products, including the D-dimer. These changes are not sufficient for differentiation of different subgroups of exudates. In transudates, these events were observed to a lesser degree.</p></span> <span id="ceabs50" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle50">CONCLUSION</span><p id="spara70" class="elsevierStyleSimplePara elsevierViewall">The coagulation system plays an important role in the development of pleural diseases. Coagulation tests show differences between transudates and exudates but not among exudate subgroups. Understanding the physiopathological mechanisms of pleural disorders may help to define new diagnostic and therapeutic approaches.</p></span>" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "ceabs10" "titulo" => "OBJECTIVE" ] 1 => array:2 [ "identificador" => "ceabs20" "titulo" => "INTRODUCTION" ] 2 => array:2 [ "identificador" => "ceabs30" "titulo" => "METHODS" ] 3 => array:2 [ "identificador" => "ceabs40" "titulo" => "RESULTS" ] 4 => array:2 [ "identificador" => "ceabs50" "titulo" => "CONCLUSION" ] ] ] ] "multimedia" => array:2 [ 0 => array:7 [ "identificador" => "f1-cln64_9p891" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1735 "Ancho" => 804 "Tamanyo" => 158395 ] ] "descripcion" => array:1 [ "en" => "<p id="spara10" class="elsevierStyleSimplePara elsevierViewall">Fibrinogen and fragment 1+2 levels (mean ± standard error) in transudates, exudates (E), parapneumonic (P), tuberculosis (Tb) and cancer (M). * p < 0.05 (x transudate)</p>" ] ] 1 => array:7 [ "identificador" => "f2-cln64_9p891" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 2006 "Ancho" => 982 "Tamanyo" => 301327 ] ] "descripcion" => array:1 [ "en" => "<p id="spara20" class="elsevierStyleSimplePara elsevierViewall">Thrombin-antithrombin complex (TAT), products of the fibrin degradation (FDP) and D-dimer levels (mean ± standard error) in transudates, exudates (E), parapneumonic (P), tuberculosis (Tb) and cancer (M). * p < 0.05 (x transudate)</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "REFERENCES" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "cebibsec10" "bibliografiaReferencia" => array:12 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pathogenesis of pleural fibrosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => """ SE Mutsaers \n \t\t\t\t\t\t\t\t """ 1 => """ CM Prele \n \t\t\t\t\t\t\t\t """ 2 => """ AR Brody \n \t\t\t\t\t\t\t\t """ 3 => """ S Idell \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1440-1843.2004.00633.x" "Revista" => array:6 [ "tituloSerie" => "Respirology" "fecha" => "2004" "volumen" => "9" "paginaInicial" => "428" "paginaFinal" => "440" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15612953" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pleural effusions: the diagnostic separation of transudates and exudates" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => """ RW Light \n \t\t\t\t\t\t\t\t """ 1 => """ MI Macgregor \n \t\t\t\t\t\t\t\t """ 2 => """ PC Luchsinger \n \t\t\t\t\t\t\t\t """ 3 => """ WC Ball Jr \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.7326/0003-4819-77-4-507" "Revista" => array:6 [ "tituloSerie" => "Ann Intern Med" "fecha" => "1972" "volumen" => "77" "paginaInicial" => "507" "paginaFinal" => "513" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/4642731" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fisiopatologia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => """ RW Light \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:6 [ "editores" => "FSVargas, LRTeixeira, EMarchi" "titulo" => "Derrame Pleural" "paginaInicial" => "33" "paginaFinal" => "46" "edicion" => "1st ed" "serieFecha" => "2004" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hypercoagulability and lung cancer" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => """ FCA Marinho \n \t\t\t\t\t\t\t\t """ 1 => """ TY Takagaki \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1590/s1806-37132008000500011" "Revista" => array:6 [ "tituloSerie" => "J Bras Pneumol" "fecha" => "2008" "volumen" => "34" "paginaInicial" => "312" "paginaFinal" => "322" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18545828" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical and laboratory parameters in the differential diagnosis of pleural effusion secondary to tuberculosis or cancer" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => """ L Antonangelo \n \t\t\t\t\t\t\t\t """ 1 => """ FS Vargas \n \t\t\t\t\t\t\t\t """ 2 => """ M Seiscento \n \t\t\t\t\t\t\t\t """ 3 => """ S Bombarda \n \t\t\t\t\t\t\t\t """ 4 => """ L Teixeira \n \t\t\t\t\t\t\t\t """ 5 => """ RK Sales \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1590/s1807-59322007000500009" "Revista" => array:6 [ "tituloSerie" => "Clinics" "fecha" => "2007" "volumen" => "62" "paginaInicial" => "585" "paginaFinal" => "590" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17952319" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Malignant and tuberculous pleural effusions: immunophenotypic cellular characterization" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => """ LM Aguiar \n \t\t\t\t\t\t\t\t """ 1 => """ L Antonangelo \n \t\t\t\t\t\t\t\t """ 2 => """ FS Vargas \n \t\t\t\t\t\t\t\t """ 3 => """ MC Zerbini \n \t\t\t\t\t\t\t\t """ 4 => """ MM Sales \n \t\t\t\t\t\t\t\t """ 5 => """ DE Uip \n \t\t\t\t\t\t\t\t """ 6 => """ PH Saldiva \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1590/s1807-59322008000500012" "Revista" => array:6 [ "tituloSerie" => "Clinics" "fecha" => "2008" "volumen" => "63" "paginaInicial" => "637" "paginaFinal" => "644" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18925324" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => """ HF Dvorak \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM198612253152606" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "1986" "volumen" => "315" "paginaInicial" => "1650" "paginaFinal" => "1659" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/3537791" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Abnormalities of pathways of fibrin turnover in the human pleural space" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => """ S Idell \n \t\t\t\t\t\t\t\t """ 1 => """ W Girard \n \t\t\t\t\t\t\t\t """ 2 => """ KB Koenig \n \t\t\t\t\t\t\t\t """ 3 => """ J McLarty \n \t\t\t\t\t\t\t\t """ 4 => """ DS Fair \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/ajrccm/144.1.187" "Revista" => array:6 [ "tituloSerie" => "Am Rev Respir Dis" "fecha" => "1991" "volumen" => "144" "paginaInicial" => "187" "paginaFinal" => "194" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/2064128" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib9" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fibrin/fibrinogen degradation products in pleural exudate" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => """ B Astedt \n \t\t\t\t\t\t\t\t """ 1 => """ G Adielsson \n \t\t\t\t\t\t\t\t """ 2 => """ W Mattsson \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "The Lancet" "fecha" => "1976" "volumen" => "308" "paginaInicial" => "414" "paginaFinal" => "416" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib10" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Proinflammatory cytokines, transforming growth factor-beta1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => """ C-L Chung \n \t\t\t\t\t\t\t\t """ 1 => """ C-H Chen \n \t\t\t\t\t\t\t\t """ 2 => """ J-R Sheu \n \t\t\t\t\t\t\t\t """ 3 => """ Y-C Chen \n \t\t\t\t\t\t\t\t """ 4 => """ S-C Chang \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1378/chest.128.2.690" "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "2005" "volumen" => "128" "paginaInicial" => "690" "paginaFinal" => "697" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16100155" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib11" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pleural fibrinolytic activity is decreased in inflammation as demonstrated in quinacrine pleurodesis treatment of malignant pleural effusion" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => """ V Agrenius \n \t\t\t\t\t\t\t\t """ 1 => """ J Chmielewska \n \t\t\t\t\t\t\t\t """ 2 => """ O Widstrom \n \t\t\t\t\t\t\t\t """ 3 => """ M Blomback \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/ajrccm/140.5.1381" "Revista" => array:6 [ "tituloSerie" => "Am Rev Respir Dis" "fecha" => "1989" "volumen" => "140" "paginaInicial" => "1381" "paginaFinal" => "1385" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/2817601" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib12" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ F Gieseler \n \t\t\t\t\t\t\t\t """ 1 => """ I Luhr \n \t\t\t\t\t\t\t\t """ 2 => """ T Kunze \n \t\t\t\t\t\t\t\t """ 3 => """ C Mundhenke \n \t\t\t\t\t\t\t\t """ 4 => """ N Maass \n \t\t\t\t\t\t\t\t """ 5 => """ T Erhart \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Thromb Haemost" "fecha" => "2007" "volumen" => "97" "paginaInicial" => "1023" "paginaFinal" => "1030" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17549306" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/18075932/0000006400000009/v1_202212060758/S1807593222025595/v1_202212060758/en/main.assets" "Apartado" => null "PDF" => "https://static.elsevier.es/multimedia/18075932/0000006400000009/v1_202212060758/S1807593222025595/v1_202212060758/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1807593222025595?idApp=UINPBA00004N" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 1 | 0 | 1 |
| 2024 October | 20 | 24 | 44 |
| 2024 September | 30 | 19 | 49 |
| 2024 August | 33 | 22 | 55 |
| 2024 July | 27 | 27 | 54 |
| 2024 June | 20 | 15 | 35 |
| 2024 May | 16 | 13 | 29 |
| 2024 April | 22 | 11 | 33 |
| 2024 March | 28 | 13 | 41 |
| 2024 February | 35 | 10 | 45 |
| 2024 January | 31 | 20 | 51 |
| 2023 December | 24 | 19 | 43 |
| 2023 November | 28 | 20 | 48 |
| 2023 October | 37 | 19 | 56 |
| 2023 September | 29 | 16 | 45 |
| 2023 August | 44 | 9 | 53 |
| 2023 July | 37 | 7 | 44 |
| 2023 June | 22 | 1 | 23 |
| 2023 May | 51 | 3 | 54 |
| 2023 April | 26 | 2 | 28 |
| 2023 March | 14 | 1 | 15 |
| 2023 February | 3 | 0 | 3 |
| 2023 January | 3 | 12 | 15 |
| 2022 December | 101 | 3 | 104 |
Show all